Conjugation of phenylacetate with glutamine

Stable Identifier
R-HSA-177162
Type
Pathway
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this pathway in the Pathway Browser

Phenylacetate metabolism is of clinical importance because its conjugation with glutamine to form phenylacetylglutamine, which can be excreted in the urine, provides an alternative pathway for nitrogen excretion in patients with urea cycle defects (James et al. 1972; Batshaw et al. 2001; Brusilow and Horwich 2001). This conjugation proceeds in two steps. First, phenylacetate and ATP react with coenzyme A to form phenylacetyl CoA, AMP, and pyrophosphate (Vessey et al. 1999). Two human CoA ligases have been characterized that catalyze this reaction efficiently in vitro: acyl-CoA synthetase medium-chain family member 1 (BUCS1) (Fujino et al. 2001) and xenobiotic/medium-chain fatty acid:CoA ligase (Vessey et al. 2003). Their relative contributions to phenylacetate metabolism in vivo are unknown. Second, phenylacetyl CoA and glutamine react to form phenyacetyl glutamine and Coenzyme A. The enzyme that catalyzes this reaction has been purified from human liver mitochondria and shown to be a distinct polypeptide species from glycine-N-acyltransferase (Webster et al. 1976). This human glutamine-N-acyltransferase activity has not been characterized by sequence analysis at the protein or DNA level, however, and thus cannot be associated with a known human protein in the annotation of phenylacetate conjugation.

Literature References
PubMed ID Title Journal Year
4403084 The conjugation of phenylacetic acid in man, sub-human primates and some non-primate species

James, MO, Smith, RL, Williams, RT, Reidenberg, M

Proc R Soc Lond B Biol Sci 1972
11148549 Alternative pathway therapy for urea cycle disorders: twenty years later

Batshaw, ML, MacArthur, RB, Tuchman, M

J Pediatr 2001
931988 Identification of separate acyl- CoA:glycine and acyl-CoA:L-glutamine N-acyltransferase activities in mitochondrial fractions from liver of rhesus monkey and man

Webster, LT, Siddiqui, UA, Lucas, SV, Strong, JM, Mieyal, JJ

J Biol Chem 1976
11470804 Molecular identification and characterization of two medium-chain acyl-CoA synthetases, MACS1 and the Sa gene product

Fujino, T, Takei, YA, Sone, H, Ioka, RX, Kamataki, A, Magoori, K, Takahashi, S, Sakai, J, Yamamoto, TT

J Biol Chem 2001
  The Metabolic and Molecular Bases of Inherited Disease, 8th ed

Scriver, CR, Beaudet, AL, Valle, D, Sly, WS

  2001
12616642 Isolation, sequencing, and expression of a cDNA for the HXM-A form of xenobiotic/medium-chain fatty acid:CoA ligase from human liver mitochondria

Vessey, DA, Lau, E, Kelley, M, Warren, RS

J Biochem Mol Toxicol 2003
10434065 Characterization of the CoA ligases of human liver mitochondria catalyzing the activation of short- and medium-chain fatty acids and xenobiotic carboxylic acids

Vessey, DA, Kelley, M, Warren, RS

Biochim Biophys Acta 1999
Participants
Participant Of
Event Information
Orthologous Events
Authored
Created